by Clinical Neuropsychologist | Monday, July 15, 2024 | Neuroimaging
Abstract Background and Purpose Quantitative susceptibility mapping (QSM), neurite orientation dispersion and density imaging (NODDI), and the g-ratio have separately shown differences between Parkinson’s disease (PD) and healthy controls. The g-ratio has,...
by Clinical Neuropsychologist | Monday, July 15, 2024 | Neuroimaging
Abstract Background and purpose Pediatric multiple sclerosis (MS) displays different pathological features compared to adult MS, which can be studied in vivo by assessing tissue magnetic susceptibility with 3T-MRI. We aimed to assess different white matter lesions...
by Clinical Neuropsychologist | Thursday, June 27, 2024 | Neuroimaging
Abstract Background and Purpose In acute ischemic stroke (AIS) due to large-vessel occlusion (LVO), the relationship between cerebral oxygen extraction fraction (OEF) as the hallmark of the ischemic penumbra and leptomeningeal collateral supply is not well...
by Clinical Neuropsychologist | Tuesday, June 11, 2024 | Neuroimaging
Abstract Background and Purpose Conclusions from prior literature regarding the impact of sex, age, and height on spinal cord (SC) MRI morphometrics are conflicting, while the effect of body weight on SC morphometrics has been found to be nonsignificant. The purpose...
by Clinical Neuropsychologist | Tuesday, June 4, 2024 | Neuroimaging
Abstract Background and purpose Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) diagnosis are based on the presence of serological and magnetic resonance imaging (MRI) biomarkers. Diffusion...
by Clinical Neuropsychologist | Wednesday, May 29, 2024 | Neuroimaging
Abstract Background and Purpose Brain arterial luminal diameters are reliably measured with automated imaging software. Nonautomated imaging software alternatives such as a Picture Archiving Communication System are more common bedside tools used for manual...
